188 related articles for article (PubMed ID: 24833135)
1. Endocrine side-effects of anti-cancer drugs: thyroid effects of tyrosine kinase inhibitors.
Illouz F; Braun D; Briet C; Schweizer U; Rodien P
Eur J Endocrinol; 2014 Sep; 171(3):R91-9. PubMed ID: 24833135
[TBL] [Abstract][Full Text] [Related]
2. Thyroid dysfunctions induced by tyrosine kinase inhibitors.
Fallahi P; Ferrari SM; Vita R; Di Domenicantonio A; Corrado A; Benvenga S; Antonelli A
Expert Opin Drug Saf; 2014 Jun; 13(6):723-33. PubMed ID: 24821006
[TBL] [Abstract][Full Text] [Related]
3. Thyroid dysfunction as an unintended side effect of anticancer drugs.
Torino F; Barnabei A; Paragliola R; Baldelli R; Appetecchia M; Corsello SM
Thyroid; 2013 Nov; 23(11):1345-66. PubMed ID: 23750887
[TBL] [Abstract][Full Text] [Related]
4. Expert opinion on thyroid complications of new anti-cancer therapies: Tyrosine kinase inhibitors.
Drui D; Illouz F; Do Cao C; Caron P
Ann Endocrinol (Paris); 2018 Oct; 79(5):569-573. PubMed ID: 30126626
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders.
Jannin A; Penel N; Ladsous M; Vantyghem MC; Do Cao C
Crit Rev Oncol Hematol; 2019 Sep; 141():23-35. PubMed ID: 31202955
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitor-induced thyroid disorders: a review and hypothesis.
Makita N; Iiri T
Thyroid; 2013 Feb; 23(2):151-9. PubMed ID: 23398161
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Disease and the Heart.
Klein I; Danzi S
Curr Probl Cardiol; 2016 Feb; 41(2):65-92. PubMed ID: 26792255
[TBL] [Abstract][Full Text] [Related]
8. Endocrine side effects of broad-acting kinase inhibitors.
Lodish MB; Stratakis CA
Endocr Relat Cancer; 2010 Sep; 17(3):R233-44. PubMed ID: 20603395
[TBL] [Abstract][Full Text] [Related]
9. Endocrine-related adverse conditions induced by tyrosine kinase inhibitors.
De Leo S; Trevisan M; Moneta C; Colombo C
Ann Endocrinol (Paris); 2023 May; 84(3):374-381. PubMed ID: 36963756
[TBL] [Abstract][Full Text] [Related]
10. Thyroid dysfunction related to vascular endothelial growth factor receptor tyrosine kinase inhibitors: A real-world study based on FAERS.
Liao X; Liu Z; Song H
J Clin Pharm Ther; 2021 Oct; 46(5):1418-1425. PubMed ID: 34169545
[TBL] [Abstract][Full Text] [Related]
11. Thyroid adverse effects of psychotropic drugs: a review.
Bou Khalil R; Richa S
Clin Neuropharmacol; 2011; 34(6):248-55. PubMed ID: 21996646
[TBL] [Abstract][Full Text] [Related]
12. Thyroid dysfunction from antineoplastic agents.
Hamnvik OP; Larsen PR; Marqusee E
J Natl Cancer Inst; 2011 Nov; 103(21):1572-87. PubMed ID: 22010182
[TBL] [Abstract][Full Text] [Related]
13. [Thyroid function and amiodarone. Consequences on dysthyroidism testing].
Fragu P; Schlumberger M
Ann Cardiol Angeiol (Paris); 1985 Jan; 34(1):5-10. PubMed ID: 3883881
[TBL] [Abstract][Full Text] [Related]
14. Drugs affecting thyroid function.
Barbesino G
Thyroid; 2010 Jul; 20(7):763-70. PubMed ID: 20578900
[TBL] [Abstract][Full Text] [Related]
15. Current evidence on thyroid related adverse events in patients treated with protein tyrosine kinase inhibitors.
Gabora K; Piciu A; Bădulescu IC; Larg MI; Stoian IA; Piciu D
Drug Metab Rev; 2019 Nov; 51(4):562-569. PubMed ID: 31718371
[TBL] [Abstract][Full Text] [Related]
16. Effects of tyrosine kinase inhibitors on thyroid function and thyroid hormone metabolism.
Basolo A; Matrone A; Elisei R; Santini F
Semin Cancer Biol; 2022 Feb; 79():197-202. PubMed ID: 33476722
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitors and the thyroid as both an unintended and an intended target.
Vetter ML; Kaul S; Iqbal N
Endocr Pract; 2008; 14(5):618-24. PubMed ID: 18753108
[TBL] [Abstract][Full Text] [Related]
18. How tyrosine kinase inhibitors impair metabolism and endocrine system function: a systematic updated review.
Breccia M; Molica M; Alimena G
Leuk Res; 2014 Dec; 38(12):1392-8. PubMed ID: 25449685
[TBL] [Abstract][Full Text] [Related]
19. [Diseases and medicaments underlying thyroid problems].
Matikainen N
Duodecim; 2010; 126(20):2439-47. PubMed ID: 21125758
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors and modifications of thyroid function tests: a review.
Illouz F; Laboureau-Soares S; Dubois S; Rohmer V; Rodien P
Eur J Endocrinol; 2009 Mar; 160(3):331-6. PubMed ID: 19103722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]